AzTrials
AzTrials

Laryngopharyngeal RefluxLPRNCT04771221

Method of Early Diagnosis of Laryngopharyngeal Reflux

A study testing pH metry, Filling out the questionnaire and Endoscopic laryngoscopy in people with Laryngopharyngeal Reflux and Laryngopharyngitis Chronic, run by Kazakh Medical University of Continuing Education at 2 sites in Kazakhstan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigator will issue a Patient Information Consent for the participant in the study. 1.Patients will be asked to complete the Reflux Symptom Index questionnaire. Clinical survey, medical history. 2. Objective methods for assessing the patient's condition: examination of ENT organs. 3. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
What is being tested?
pH metry, Filling out the questionnaire and Endoscopic laryngoscopy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
385 participants
Where
2 sitesKazakhstan
Study dates
10 Jan 2021to 15 Feb 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patient's informed consent
  • Age: 18-75 years old
  • No serious somatic diseases.
  • Patients with complaints of sore throat, coughing, burning sensation in the throat, coughing, frequent sore throat, difficulty swallowing, lump in the throat, foreign body feeling in the throat, voice changes, heartburn and belching.
  • Diagnosis: Chronic pharyngitis
  • Chronic laryngitis

Who cannot join

  • Disagreement to participate in scientific research
  • Age: under 18 and over 76
  • Severe somatic diseases, organic lesions of the gastrointestinal tract and ENT organs
  • Patients with pulmonary pathologies
  • Patients with allergic manifestations (seasonal hay fever, asthma, etc.)
  • With diagnoses: Acute respiratory diseases
  • Patients with general neuralgic disorders

Trial locations and contacts

2 sites in 1 country.

Kazakhstan2 sites
  • SOS Medical Assistance

    Almaty

  • V-ent

    Almaty

Other trials in Kazakhstan

About this study

Official title: Method of Early Diagnosis of Laryngopharyngeal Reflux in an Outpatient Appointment of an Otorhinolaryngologist

The investigator will issue a Patient Information Consent for the participant in the study. 1.Patients will be asked to complete the Reflux Symptom Index questionnaire.

Clinical survey, medical history. 2. Objective methods for assessing the patient's condition:

  • examination of ENT organs. 3. Laboratory and instrumental research methods: Endoscopic laryngoscopy and video laryngoscopy, pH-metry, acoustic voice analysis.

4.Sociological method. 5. Subjective methods for assessing the condition of the larynx. 6. Аnalysis of the received data

Read the detailed description

The investigator will issue a Patient Information Consent for the participant in the study. 1.Patients will be asked to complete the Reflux Symptom Index questionnaire.

Clinical survey, medical history 2. Objective methods for assessing the patient's condition:

  • examination of ENT organs: rhinoscopy, otoscopy, pharyngoscopy and laryngoscopy 3. Laboratory and instrumental research methods - Endoscopic laryngoscopy and video laryngoscopy. pH-metry: The collection of mucus from the laryngopharynx for the determination of acid-base values. Acoustic voice analysis: objective assessment of the voice condition 4.Sociological method: determination of lifestyle, nutrition, the presence or absence of bad habits.
  1. Subjective methods for assessing the condition of the larynx - Questionnaires.
  2. Аnalysis of the received data
Being tested
pH metry, Filling out the questionnaire, Endoscopic laryngoscopy, Acoustic voice analysis
Keywords
Laryngopharyngeal Reflux, Laryngopharyngitis Chronic, Gastro Esophageal Reflux, Laryngitis, pH monitoring, pH metric, acoustic voice analysis
Medical subject headings
Laryngopharyngeal Reflux, Gastroesophageal Reflux, Laryngitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • pH metryDiagnostic test

    The collection of mucus from the laryngopharynx to determine the acid-base values through pH-metry.

  • Filling out the questionnaireDiagnostic test

    Completion of the questionnaire index of reflux symptoms. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. Evaluation results range from 0 to 5, where 0 is an indicator of no problem, and 5 is an indicator of a serious problem

  • Endoscopic laryngoscopyDevice

    Video laryngoscopy and assessment of the presence / severity of the symptoms. Evaluation results range from 0 to 4, where 0 is an indicator of no problem, and 4 is an indicator of a serious problem

  • Acoustic voice analysisDevice

    acoustic analysis of the voice was performed in singers with voice disorders before and after treatment using program of the Lingwaves

Study groups in NCT04771221
Study groupRoleWhat they receive
Main groupExperimentalPatients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching.
Receives: Diagnostic Test: pH metry; Diagnostic Test: Filling out the questionnaire; Device: Endoscopic laryngoscopy; Device: Acoustic voice analysis
Control group 1ExperimentalPatients with an early diagnosis of Gastroesophageal reflux disease
Receives: Diagnostic Test: pH metry; Diagnostic Test: Filling out the questionnaire; Device: Endoscopic laryngoscopy
Control group 2ExperimentalPatients without complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching.
Receives: Diagnostic Test: pH metry; Diagnostic Test: Filling out the questionnaire; Device: Endoscopic laryngoscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acidity level of the main group, Week 0

    The acidity level of the larynx is assessed using litmus paper. The range of acidity levels is from 4.5 to 9.0, where below 6.5 indicates the acidity of the environment, above 7.5 - alkalinity.

    Measured: at the inclusion to the study

  2. Acidity level of the control group 1, Week 0

    The acidity level of the larynx is assessed using litmus paper. The range of acidity levels is from 4.5 to 9.0, where below 6.5 indicates the acidity of the environment, above 7.5 - alkalinity.

    Measured: at the inclusion to the study

  3. Acidity level of the control group 2, Week 0

    The acidity level of the larynx is assessed using litmus paper. The range of acidity levels is from 4.5 to 9.0, where below 6.5 indicates the acidity of the environment, above 7.5 - alkalinity.

    Measured: at the inclusion to the study

  4. "Index of reflux symptoms" of the main group, Week 0

    Patients will be asked to complete the Reflux Symptom Index questionnaire. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. The severity of the problem is calculated as the summation of all points. The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.

    Measured: at the inclusion to the study

  5. "Index of reflux symptoms" of the control group 1, Week 0

    Patients will be asked to complete the Reflux Symptom Index questionnaire. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. The severity of the problem is calculated as the summation of all points. The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.

    Measured: at the inclusion to the study

  6. "Index of reflux symptoms" of the control group 2, Week 0

    Patients will be asked to complete the Reflux Symptom Index questionnaire. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. The severity of the problem is calculated as the summation of all points. The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.

    Measured: at the inclusion to the study

  7. Endoscopic laryngoscopy of the main group, Week 0

    Assessment of the state of the larynx on the scale of reflux symptoms. Where the presence and severity of the sign is assessed in points from 0 to 4. Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.

    Measured: at the inclusion to the study

  8. Endoscopic laryngoscopy of the control group 1, Week 0

    Assessment of the state of the larynx on the scale of reflux symptoms. Where the presence and severity of the sign is assessed in points from 0 to 4. Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.

    Measured: at the inclusion to the study

  9. Endoscopic laryngoscopy of the control group 2, Week 0

    Assessment of the state of the larynx on the scale of reflux symptoms. Where the presence and severity of the sign is assessed in points from 0 to 4. Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.

    Measured: at the inclusion to the study

  10. Acoustic voice analysis of the main group, Week 0

    Acoustic analysis of the voice was performed in patients with a voice profession who had a voice disorder using computer program of the Lingwaves.

    Measured: at the inclusion to the study

Secondary outcomes (10)
  1. Acidity level of the main group, Week 4

    The acidity level of the larynx is assessed using litmus paper. The range of acidity levels is from 4.5 to 9.0, where above 7.5 indicates the alkalinity of the medium, below 6.5 - acidic.

    Measured: at 4 weeks after initial treatment

  2. Acidity level of the control group 1, Week 4

    The acidity level of the larynx is assessed using litmus paper. The range of acidity levels is from 4.5 to 9.0, where above 7.5 indicates the alkalinity of the medium, below 6.5 - acidic.

    Measured: at 4 weeks after initial treatment

  3. Acidity level of the control group 2, Week 4

    The acidity level of the larynx is assessed using litmus paper. The range of acidity levels is from 4.5 to 9.0, where above 7.5 indicates the alkalinity of the medium, below 6.5 - acidic.

    Measured: at 4 weeks after initial treatment

  4. "Index of reflux symptoms" of the main group, Week 4

    Patients will be asked to complete the Reflux Symptom Index questionnaire. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. The severity of the problem is calculated as the summation of all points. The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.

    Measured: at 4 weeks after initial treatment

  5. "Index of reflux symptoms" of the control group 1, Week 4

    Patients will be asked to complete the Reflux Symptom Index questionnaire. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. The severity of the problem is calculated as the summation of all points. The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.

    Measured: at 4 weeks after initial treatment

  6. "Index of reflux symptoms" of the control group 2, Week 4

    Patients will be asked to complete the Reflux Symptom Index questionnaire. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. The severity of the problem is calculated as the summation of all points. The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.

    Measured: at 4 weeks after initial treatment

  7. Endoscopic laryngoscopy of the main group, Week 4

    Assessment of the state of the larynx on the scale of reflux symptoms. Where the presence and severity of the sign is assessed in points from 0 to 4. Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.

    Measured: at 4 weeks after initial treatment

  8. Endoscopic laryngoscopy of the control group 1, Week 4

    Assessment of the state of the larynx on the scale of reflux symptoms. Where the presence and severity of the sign is assessed in points from 0 to 4. Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.

    Measured: at 4 weeks after initial treatment

  9. Endoscopic laryngoscopy of the control group 2, Week 4

    Assessment of the state of the larynx on the scale of reflux symptoms. Where the presence and severity of the sign is assessed in points from 0 to 4. Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.

    Measured: at 4 weeks after initial treatment

  10. Acoustic voice analysis of the main group, Week 4

    Acoustic analysis of the voice was performed in patients with a voice profession who had a voice disorder using computer program of the Lingwaves

    Measured: at 4 weeks after initial treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Feb 2021
  2. Study start10 Jan 2021
  3. Primary completion15 Feb 2022
  4. Study completion15 Feb 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
385 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04771221
Sponsor's protocol ID
14-2020
Other IDs
14-2020
Acronym
LPR
Status last verified
Apr 2022
First submitted
23 Feb 2021
Last updated
10 Jan 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing pH metry, Filling out the questionnaire and Endoscopic laryngoscopy in people with Laryngopharyngeal Reflux and Laryngopharyngitis Chronic, run by Kazakh Medical University of Continuing Education at 2 sites in Kazakhstan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Kazakhstan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acidity level of the main group, Week 0 (time frame: at the inclusion to the study). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in